Tagged with P

Portugal Jorge Sequeira, general manager for Cerner Portugal, sheds light on Portuguese prowess in healthcare technology. Jorge covers themes ranging from revolutionizing electronic medical records (EMR), uptake of new technologies in healthcare and Cerner Portugal’s overall mission of promoting health, rather than treating disease.               …

Novartis In the latest in a wave of Big Pharma companies retreating from the field of antibiotics, Novartis has decided to drop its antibacterial and antiviral early-stage research programs, laying off 140 staff in the US. This comes at a time when antibiotic-resistant strains of bacteria – so-called ‘superbugs’ – are…

Portugal Mario Madeira, general manager of Teva Portugal, highlights the milestones of the affiliate in Portugal, referencing the economic crisis and where Teva is now positioned in the country. In addition, he comments on Portugal’s great potential for digitalizing its healthcare sector. What are Teva Portugal’s priorities for 2018? “Teva is…

Spain Enrique Sánchez de León, president of Fundamed, discusses the role of the voice of the patients, and how they work alongside the General Patient Alliance to strengthen this voice. Furthermore, he highlights the importance of the Fundamed awards as a way to give back to those committed to the healthcare…

Portugal RJ Lasek took on his first country lead position in Portugal in 2016 and has successfully reshaped the affiliate to match global operations, forecasting 40 percent growth for 2018. In this interview, he sheds light on how to excel in the challenging pharmaceutical landscape–particularly with reimbursement restrictions and what characterizes…

UK Having recently joined the UK operations of AstraZeneca after a varied international career, Laurent Abuaf shares his vision of the UK as a life sciences reference market and his take on what makes the NHS so unique. Moreover, he highlights some exciting elements of AstraZeneca’s pipeline and reaffirms the company’s…

Turkey The top 15 pharma companies in Turkey ranked by sales for 2017. Homegrown champion Ibrahim leads the way with USD 420 million worth of sales and a 5.8 percent market share, followed by global giants Novartis and Pfizer.

UK Heading Accord Healthcare’s European, Middle East and North African operations, James Burt highlights the rapid growth the company has achieved within the region and how it has reached an impressive double-digit market share in the UK, putting Accord firmly on track to attain their goal of becoming a top 5…

Portugal Similar to many Western economies, Portugal is attempting to embrace digitalization in healthcare, but unlike Europe’s Big Five which struggle due to huge populations and decentralized systems, thanks to Portugal’s size and tech-savvy population, industry players and authorities have found success in implementing nationwide digital projects. “We benefit from a…

UK Promoting the UK’s capital in times of Brexit, Laura Citron, CEO at London & Partners, the international promotional agency of the Mayor of London, stresses the critical importance life sciences hold as a sector for the city’s economy. With its potential to create good jobs improving the live of Londoners,…

Malta Malta has the second largest pharma trade balance per capita in the EU, the tenth in total, and was the continent’s fastest growing pharma exporter between 2001 and 2016. Malta acts a flight hub for southern Europe, with 35,000 international departures and arrivals per annum. Doing business in Malta is…

India Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming years, Indian companies have – in the meantime – been rapidly increasing their efforts to develop stronger footprints in strategic emerging market such as Brazil, Russia and some Asian and African…